InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: akhsv777 post# 46501

Wednesday, 04/03/2019 8:26:14 AM

Wednesday, April 03, 2019 8:26:14 AM

Post# of 48316
Yesterday's data at AACR spelled out the potential. The new multi-gene construct is a next-generation improvement over Oncosec's current platform. I think they could see a licensing deal from this with the announcement of a new pipeline similar to what Jounce/Celgene did. Could spell big money at any time really. If it happens it happens, if not I am confident PISCES will get an approval next year and we are looking at a much higher share price anyway.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News